NEW YORK, March 7 (GenomeWeb News) - Sanofi-Aventis has licensed Ingenuity Content and Ingenuity Pathways Analysis software for global deployment, Ingenuity said today.
The deal is an expansion of a licensing agreement between the companies dating to 2003.
Financial details were not provided.